High-load Resistance Training Compared With Usual Care for Treatment of Painful Knee Joint Hypermobility in Young Adults: A Randomised Controlled Trial (the HIPEr-Knee Study)

Status: Recruiting
Location: See all (2) locations...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Pain associated with knee joint hypermobility is common in the adult population, but evidence on treatment is sparse. This study investigates if high-load resistance training is superior to usual care in improving activity-related pain in young patients (18-45 years) with hypermobile joints and knee pain.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 45
Healthy Volunteers: f
View:

• Persistent knee pain for ≥ 3 months (self-reported)

• Knee pain ≥ 30mm during the last week using a 0-100 mm visual analogue scale (VAS; 0=no pain and 100=worst imaginable pain) (self-reported)

• Generalised joint hypermobility assessed with the Five-Part Hypermobility Questionnaire (positive ≥ 2/5) (self-reported)

• Local knee joint hypermobility using the passive hyperextension of the knee in standing (positive \> 10 degrees of hyperextension) and confirmed in supine lying (heel resting on 20 cm high block on the bench surface), with passive knee hyperextension (positive \> 10 degrees) (objectively measured)

Locations
Other Locations
Denmark
Physiotherapy Clinics Region of Southern Denmark
RECRUITING
Odense
University of Southern Denmark
RECRUITING
Odense
Contact Information
Primary
Behnam Liaghat, PhD
bliaghat@health.sdu.dk
+4526826801
Time Frame
Start Date: 2024-02-21
Estimated Completion Date: 2026-06-01
Participants
Target number of participants: 90
Treatments
Experimental: Intervention
Progressive high-load resistance training program performed twice weekly for 12 weeks
Active_comparator: Standard care
The standard care group will receive instructions on a neuromuscular training program with focus on knee stability and function performed at low intensities to be conducted twice weekly for 12 weeks
Related Therapeutic Areas
Sponsors
Leads: University of Southern Denmark
Collaborators: Independent Research Fund Denmark, Odense Patient Data Explorative Network

This content was sourced from clinicaltrials.gov